These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 16888228

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Novel extended and branched N-terminal analogs of VIP.
    Dangoor D, Rubinraut S, Fridkin M, Gozes I.
    Regul Pept; 2006 Nov 15; 137(1-2):42-9. PubMed ID: 16962672
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Generation of PEGylated VPAC1-selective antagonists that inhibit proliferation of a lung cancer cell line.
    Pan CQ, Hamren S, Roczniak S, Tom I, DeRome M.
    Peptides; 2008 Mar 15; 29(3):479-86. PubMed ID: 17942192
    [Abstract] [Full Text] [Related]

  • 30. Genetic association of vasoactive intestinal peptide receptor with rheumatoid arthritis: altered expression and signal in immune cells.
    Delgado M, Robledo G, Rueda B, Varela N, O'Valle F, Hernandez-Cortes P, Caro M, Orozco G, Gonzalez-Rey E, Martin J.
    Arthritis Rheum; 2008 Apr 15; 58(4):1010-9. PubMed ID: 18383379
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.
    Sun W, Hong J, Zang YC, Liu X, Zhang JZ.
    Int Immunol; 2006 Dec 15; 18(12):1691-700. PubMed ID: 17077178
    [Abstract] [Full Text] [Related]

  • 33. Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts.
    Juarranz Y, Gutiérrez-Cañas I, Santiago B, Carrión M, Pablos JL, Gomariz RP.
    Arthritis Rheum; 2008 Apr 15; 58(4):1086-95. PubMed ID: 18383383
    [Abstract] [Full Text] [Related]

  • 34. Novel glycosylated VIP analogs: synthesis, biological activity, and metabolic stability.
    Dangoor D, Biondi B, Gobbo M, Vachutinski Y, Fridkin M, Gozes I, Rocchi R.
    J Pept Sci; 2008 Mar 15; 14(3):321-8. PubMed ID: 17924396
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Vasoactive intestinal polypeptide (VIP) and VPAC1 receptor in adult human dental pulp in relation to caries.
    El Karim IA, Lamey PJ, Ardill J, Linden GJ, Lundy FT.
    Arch Oral Biol; 2006 Oct 15; 51(10):849-55. PubMed ID: 16806045
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Comparative efficacy of VIP and analogs on activation and internalization of the recombinant VPAC2 receptor expressed in CHO cells.
    Langlet C, Gaspard N, Nachtergael I, Robberecht P, Langer I.
    Peptides; 2004 Dec 15; 25(12):2079-86. PubMed ID: 15572195
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.